全文获取类型
收费全文 | 24002篇 |
免费 | 2467篇 |
国内免费 | 105篇 |
专业分类
耳鼻咽喉 | 196篇 |
儿科学 | 912篇 |
妇产科学 | 653篇 |
基础医学 | 3412篇 |
口腔科学 | 371篇 |
临床医学 | 3467篇 |
内科学 | 5180篇 |
皮肤病学 | 575篇 |
神经病学 | 2498篇 |
特种医学 | 558篇 |
外国民族医学 | 4篇 |
外科学 | 2342篇 |
综合类 | 206篇 |
一般理论 | 5篇 |
预防医学 | 2411篇 |
眼科学 | 296篇 |
药学 | 1568篇 |
中国医学 | 19篇 |
肿瘤学 | 1901篇 |
出版年
2023年 | 244篇 |
2022年 | 377篇 |
2021年 | 762篇 |
2020年 | 607篇 |
2019年 | 917篇 |
2018年 | 1008篇 |
2017年 | 787篇 |
2016年 | 836篇 |
2015年 | 884篇 |
2014年 | 1068篇 |
2013年 | 1452篇 |
2012年 | 1848篇 |
2011年 | 1754篇 |
2010年 | 1123篇 |
2009年 | 1003篇 |
2008年 | 1502篇 |
2007年 | 1488篇 |
2006年 | 1375篇 |
2005年 | 1287篇 |
2004年 | 1213篇 |
2003年 | 1081篇 |
2002年 | 1002篇 |
2001年 | 216篇 |
2000年 | 196篇 |
1999年 | 215篇 |
1998年 | 240篇 |
1997年 | 189篇 |
1996年 | 148篇 |
1995年 | 148篇 |
1994年 | 128篇 |
1993年 | 108篇 |
1992年 | 83篇 |
1991年 | 90篇 |
1990年 | 87篇 |
1989年 | 75篇 |
1988年 | 66篇 |
1987年 | 48篇 |
1986年 | 64篇 |
1985年 | 56篇 |
1984年 | 61篇 |
1983年 | 61篇 |
1982年 | 69篇 |
1981年 | 69篇 |
1980年 | 41篇 |
1979年 | 28篇 |
1978年 | 35篇 |
1977年 | 42篇 |
1976年 | 50篇 |
1975年 | 38篇 |
1974年 | 38篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
C. Noonan M. Farrell J. Mullaney H. Cassidy M. A. Asghar B. J. Young Marie Hickey-Dwyer A. Patterson W. Power M. Hillery A. Benedict-Smith L. M. T. Collum S. Fitzsimon E. O’Donoghue R. Hitchings G. B. Arden A. O’Mahony A. Murray A. Whyte M. Shehata Hugh O’Donoghue Rosemary Robinson J. Toland P. Eustace 《Irish journal of medical science》1991,160(10):322-324
42.
43.
Brian F O'Donnell Marcia A Wilt Ann Marie Hake Julie C Stout Sandra C Kirkwood Tatiana Foroud 《Movement disorders》2003,18(9):1027-1034
Disturbances of visual cognition, visuomotor performance, and visual memory have been described frequently in Huntington's disease (HD). Early stage visual abnormalities could contribute to these deficits. We evaluated visual processing in 20 control subjects who were non-gene carriers at risk for HD, nine presymptomatic gene-positive subjects, and eight subjects with a recent diagnosis of Huntington's disease. Visual perceptual tests of contrast sensitivity and motion discrimination were used to probe early stage visual processing. Extraocular movements were evaluated in a neurologic examination, and the Digit Symbol test was used to test visual motor performance. Contrast sensitivity did not differ among the three groups. Motion discrimination was impaired in HD subjects but not in the presymptomatic gene carriers when compared to gene noncarriers. Among gene carriers, impaired motion discrimination performance was associated with poorer Digit Symbol performance and extraocular abnormalities. These findings suggest that the early stages of HD are associated with disturbances of motion perception as well as disruptions of visual motor and ocular motor performance. 相似文献
44.
45.
46.
D Modrowski L Miravet M Feuga F Bannié P J Marie 《Journal of bone and mineral research》1992,7(8):961-969
To evaluate whether treatment with a mitogenic agent may increase bone formation and bone mass in osteopenia induced by estrogen deficiency, we determined the effect of oral fluoride treatment on bone and bone cells in ovariectomized rats. Sodium fluoride (NaF) was administered to 3-month-old ovariectomized rats 1 day after ovariectomy (OVX) for 1, 3, and 6 months. NaF was given in drinking water at the dose of 1 mg/kg body weight per day. Fluoride administration led to a partial prevention of the bone loss induced by OVX as shown by histologic analysis of tibial metaphysis and by evaluation of femoral calcium content. These beneficial effects of fluoride were more striking at early time points (1 and 3 months postovariectomy) than after 6 months of treatment. The increase in trabecular bone volume in OVX rats treated with fluoride was associated with a rise in the osteoblast surface, which was increased by 60, 72, and 235% at 1, 3, and 6 months postovariectomy compared to untreated OVX rats. In OVX rats and in sham-operated rats plasma osteocalcin was increased in correlation with the osteoblast surface. However, these two parameters were not correlated in OVX rats treated with fluoride. The heat-labile bone-specific alkaline phosphatase in plasma was decreased in OVX rats treated with fluoride compared to OVX rats, suggesting that both the number and the activity of osteoblasts were affected by NaF treatment. To examine the effect of fluoride on the osteocalcin production and the proliferative capacity of bone cells, osteoblastic cells were isolated by collagenase digestion from the bone surface of tibia in treated and untreated OVX rats.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
47.
Eileen Trafimow Ph.D. Marie Weissbourd Ph.D. Judith Wilen Ph.D. 《Journal of Child and Adolescent Group Therapy》1992,2(3):141-148
Traditionally, psychotherapy groups for children included only relatively intact youngsters. This paper describes a group consisting of four (near) psychotic children and two co-therapists which met for over three years. The developmental changes which occurred in the group over the course of time will be identified and discussed using a neo-psychoanalytic, object relations framework. 相似文献
48.
Augusto Giussani Adeseye M Arogunjo Marie Claire Cantone Federico Tavola Ivan Veronese 《Applied radiation and isotopes》2006,64(6):639-644
The intestinal absorption of molybdenum in healthy human volunteers has been measured by simultaneous oral and intravenous administration of the stable isotopes 95Mo and 96Mo, and the results were analysed using the convolution integral technique. The results showed that molybdenum ingested in liquid form was rapidly and totally absorbed into the circulation under ordinary intake regimes. The rates and extent of absorption were lower for composite meals, and also for increasing levels of administration. This information can be helpful in the application of the new ICRP model of the human alimentary tract. 相似文献
49.
50.
Staffan Eksborg Lennart Hardell Nils-Olof Bengtsson Marie Sjödin Birgitta Elfsson 《Medical oncology (Northwood, London, England)》1992,9(2):75-80
Sixty women with breast cancer (mean age: 61 years; range 36-78 years) were treated with Epirubicin (4’epi-Dox-orubicin),
60 mg m-2 , as single drug therapy. The drug was administered as 2 hours’ constant rate infusions. The pharmacokinetics of the drug
during the first course of treatment was evaluated by measurements of the plasma concentration of Epirubicin at the end of
the infusion period.
There was a five-fold inter-individual variation of the dose-normalized maximum plasma concentration, which increased with
increasing age of the patients. There was no correlation between this pharmacokinetic parameter and degree of obesity. 相似文献